There are 297 resources available
Which systemic therapies for vulvar cancer: Now and tomorrow
Presenter: Elsa Kalbacher
Session: Gynaecological cancers
Resources:
Slides
Webcast
When to consider perioperative chemotherapy?
Presenter: Suzanne George
Session: Retroperitoneal sarcoma
Resources:
Slides
Webcast
What to do with rare histotypes?
Presenter: Roberta Sanfilippo
Session: Retroperitoneal sarcoma
Resources:
Slides
Webcast
GTD: What next?
Presenter: Michael Seckl
Session: Gynaecological cancers
Resources:
Slides
Webcast
Q&A and discussion
Session: Retroperitoneal sarcoma
Resources:
Webcast
Q&A and discussion
Session: Gynaecological cancers
Resources:
Webcast
57MO - Impact of nirogacestat (niro) on patient-reported outcomes (PROs) in adults with desmoid tumor with a best overall response (BOR) of stable disease (SD): Post hoc analysis from the DeFi study
Presenter: Silvia Stacchiotti
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
Introduction and first vote
Presenter: Claudia María Valverde Morales
Session: The mandatory centralisation of care in rare cancer reference centres: Does it always serve the patient benefit?
Resources:
Slides
Webcast
58MO - Evaluation of three pexidartinib doses in a global phase IV clinical study of patients with tenosynovial giant cell tumor (TGCT) who chose to continue treatment
Presenter: Silvia Stacchiotti
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast
59MO - COTESARC – A multicentre, phase I-II clinical trial evaluating the combination of MEK and PDL-1 inhibitors in patients (pts) with advanced soft tissue sarcoma (STS): Results from complex (CG) and simple genomic (SG) STS cohorts
Presenter: Armelle Dufresne
Session: Mini Oral session
Resources:
Abstract
Slides
Webcast